Elutia (ELUT) Gains from Investment Securities (2023 - 2026)
Elutia (ELUT) posted Gains from Investment Securities of $1.7 million for Q1 2026, up 282.67% sequentially from -$906000.0 in Q4 2025, and up 131.91% YoY from $713649.1 in Q1 2025.
Elutia (ELUT) Gains from Investment Securities (2023 - 2026) Analysis & Trends
Elutia has reported Gains from Investment Securities for 4 years, with the latest figure at $1.7 million in Q1 2026.
- Quarterly Gains from Investment Securities rose 131.91% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.5 million (down 12227.78% YoY) and the FY2025 annual result came in at -$13.4 million, down 190.23% from the prior year.
- Gains from Investment Securities grew to $1.7 million in Q1 2026 per ELUT's latest filing, from -$906000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $18.3 million in Q2 2024 and troughed at -$12.7 million in Q3 2024.
- A 4-year average of $662000.0 and a median of -$906000.0 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2024 and 2026: Gains from Investment Securities tumbled 1082.52% in 2024, then jumped 131.91% in 2026.
- Over 4 years, Gains from Investment Securities stood at $5.2 million in 2023, then sank by 108.5% to -$443000.0 in 2024, then tumbled by 104.51% to -$906000.0 in 2025, then soared by 282.67% to $1.7 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.7 million, -$906000.0, and -$5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Elutia | 39.84 Mn | 19.94 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | -906,000.00 |
| Dec 31, 2025 | -906,000.00 |
| Sep 30, 2025 | -5.10 Mn |
| Sep 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | -2.20 Mn |
| Jun 30, 2025 | -2.20 Mn |
| Mar 31, 2025 | -5.19 Mn |
| Mar 31, 2025 | -5.19 Mn |
| Dec 31, 2024 | -443,000.00 |
| Dec 31, 2024 | -443,000.00 |
| Sep 30, 2024 | -12.65 Mn |
| Sep 30, 2024 | -12.65 Mn |
| Jun 30, 2024 | 18.34 Mn |
| Jun 30, 2024 | 18.34 Mn |
| Mar 31, 2024 | 9.64 Mn |
| Mar 31, 2024 | 9.64 Mn |
| Dec 31, 2023 | 5.21 Mn |
| Dec 31, 2023 | 5.21 Mn |